Replies to post #243021 on NorthWest Biotherapeutics Inc (NWBO)

[tryn2]

Occam’s razor says Duffy didn’t just jump from a successful position at BP Merck to tiny startup NWBO for no reason. Either he has sniffed out that DCVAX is the next big thing (unlikely because where would he get any additional information than what is available to us) or his hire is a huge indicator that LP is in negotiations with Merck for either partnership or buyout. My guess is that currently Merck and NWBO are far apart on numbers and an agreement has been made for Merck to LEND Duffy to NWBO to help them get DCVAX-L across the finish line, with as many indications as possible. When this happens, Merck will have a sure thing, and buy NWBO for the amount LP is pushing for.

[photonic5]

I took a huge risk on NWBO when I started buying at .16-.18 a share back in 2017. The alphapuppy had been speaking highly of this technology back in 2014-2016 when they were trading at $7-$10 a share. I had some unfortunate events in my life that precluded me buying then. I started my NWBO investment in July 2017.

Bigger jumped in right after I did.

My buying was highly speculative and the company was on the brink of financial failure. But I continue to believe in the technology and their data. I’ve added along the way and watched it jump to .35-.40 and back to .20 a few times. It’s been quite the ride.

I think we’re close to the end of this roller coaster, but I’ve said that before. I’ve never felt more confident. I’d love to see a buyout at $15 or more. The only thing I’d love more is if this platform starts us on a road to cure for patients. I’ve seen more death and despair than I’ve cared to in my career. A career in cancer care takes its toll and I have some memories of young people battling that I can’t forget. I want nothing more than to give hope to humans suffering from cancer. I have my money where my mouth is. If this vaccine puts hope into GBM, it can put hope anywhere.

I’m so looking forward to topline data. I want DCVAX to validate the work of Dr. Liau and Dr. Bosch and validate the risk that LP and patient investors have taken to get across the finish line. I sense that we’ll get some answers on the science and on the market in the next 60 days. If there truly is a significant naked short position, it would be heavily exposed by some positive data announcements.

I normally enjoy fireworks in July, but we can have some for Halloween this year.

[Sojourner55]

Agreed Marzan.